Curie.Bio

📍 Remote, United States🗓 Founded 2022👥 48 employees💰 Last funded 2023
Biotechnology Research🌐 curie.bio
Website LinkedIn
Curie.Bio is a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics companies. Curie.Bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services - everything a founder needs to get from concept to a compelling quality dataset that enables an awesome Series A financing. In a nutshell, we want founders in control of their own company and focused on their area of expertise and creativity, while we help make the rest happen smoothly.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
China
1
United States
1
Frequently asked questions
Who invested in Curie.Bio?
Curie.Bio has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Curie.Bio last raise funding?
The most recent investment in Curie.Bio recorded on gritt.io was in 2023.
When was Curie.Bio founded?
Curie.Bio was founded in 2022.
What industry is Curie.Bio in?
Curie.Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Curie.Bio based?
Curie.Bio is headquartered in Remote, United States.